Corrigendum: A minimally manipulated preservation and virus inactivation method for amnion/chorion

Shang Zhang, Lichang Gao, Pin Wang, Yuyan Ma, Xiaoliang Wang, Jie Wen, Yu Cheng, Changlin Liu, Chunxia Zhang, Changfeng Liu, Yongli Yan, Zhao Cheng-ruFrontiers in Bioengineering and Biotechnology 2023 · DOI · OpenAlex

Abstract

This article serves as a formal correction to the research paper "A minimally manipulated preservation and virus inactivation method for amnion/chorion," originally published in Frontiers in Bioengineering and Biotechnology (DOI: 10.3389/fbioe.2022.952498). The primary objective of this corrigendum is to rectify a clerical error in the reporting of viral inactivation data for the chorion layer of placental tissue. The corrected data reaffirms that the Ultraviolet-Riboflavin (UV-RB) treatment effectively reduces viral loads to safe levels, supporting the clinical utility of these tissues in regenerative medicine.

Introduction

Human placental tissues, specifically the amnion and chorion, have become cornerstones in the treatment of chronic, non-healing wounds such as diabetic foot ulcers (DFUs). These tissues are rich in essential growth factors (GFs), cytokines, and extracellular matrix components that promote healing and reduce inflammation. However, the use of human donor tissue necessitates rigorous screening and processing to eliminate the risk of viral transmission.

The challenge in processing these tissues lies in achieving "minimal manipulation." Regulatory frameworks often distinguish between tissues that are simply processed and those that are significantly altered (becoming "biologic drugs"). To maintain the "tissue product" status, sterilization methods must be effective yet gentle enough to preserve the biological scaffold and biochemical potency.

The UV-RB Inactivation Method

The researchers developed a method utilizing Ultraviolet-Riboflavin (UV-RB) inactivation. This process involves:

  1. Riboflavin (Vitamin B2): Serving as a non-toxic photosensitizer.
  2. UVB Irradiation: Triggering a photochemical reaction where riboflavin binds to and damages viral nucleic acids (DNA and RNA), preventing viral replication.

The study aimed to identify the minimum UVB dosage required to achieve a significant log reduction in viral activity across both the amnion and chorion layers.

Corrected Data for the Chorion Layer

In the original publication, Table 3 (intended for the chorion layer) was inadvertently published as a duplicate of Table 2 (the amnion layer). While the amnion and chorion are both parts of the placental sac, they differ in thickness and structural composition. It was therefore critical to provide the specific, unique data for the chorion to validate the method's efficacy across the entire tissue graft.

The corrected Table 3 presents the viral reduction values (measured in log units) for four model viruses:

  • PRV (Pseudorabies virus): Large, enveloped DNA virus.
  • Sindbis virus: Small, enveloped RNA virus.
  • EMCV (Encephalomyocarditis virus): Small, non-enveloped RNA virus.
  • PPV (Porcine parvovirus): Small, non-enveloped DNA virus, known for its high resistance to inactivation.
Table 3: Viral reduction of chorion (values in log) by UV-RB

Results and Discussion

The data in Table 3 demonstrates a clear threshold for efficacy. At 0 Joules (baseline), the inherent viral reduction was minimal, ranging from 1.19 to 1.94 log units. However, upon the application of 4 Joules of UVB irradiation, there was a significant increase in viral clearance.

At dosages of 4, 5, and 6 Joules, the reduction reached the detection limits of the assay for all tested viruses. Specifically, at the 4 Joule threshold, the log reductions were:

  • PRV: ≥6.14
  • Sindbis: ≥6.25
  • EMCV: ≥6.84
  • PPV: ≥5.40

The successful inactivation of PPV (≥5.40 log reduction) is particularly noteworthy, as this virus is often used as a benchmark for the most difficult-to-inactivate pathogens.

Conclusion

The corrected data confirms that the chorion layer responds to UV-RB treatment with the same high level of viral safety as the amnion layer. This corrigendum ensures the scientific record accurately reflects the robustness of the "minimally manipulated" preservation method. By achieving significant viral reduction at 4 Joules without compromising tissue integrity, this method provides a reliable pathway for the safe clinical application of placental tissues in wound care and regenerative therapies.

Summary updated

Abstract

[This corrects the article DOI: 10.3389/fbioe.2022.952498.].
BibTeX
@inproceedings{zhang2023corrigendum,
  author = {Shang Zhang and Lichang Gao and Pin Wang and Yuyan Ma and Xiaoliang Wang and Jie Wen and Yu Cheng and Changlin Liu and Chunxia Zhang and Changfeng Liu and Yongli Yan and Zhao Cheng-ru},
  title = {{Corrigendum: A minimally manipulated preservation and virus inactivation method for amnion/chorion}},
  booktitle = {Frontiers in Bioengineering and Biotechnology},
  year = {2023},
  doi = {10.3389/fbioe.2023.1210771},
}
Figure